Related references
Note: Only part of the references are listed.A Budget Impact and Cost Per Additional Responder Analysis for Baricitinib for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients with an Inadequate Response to Tumor Necrosis Factor Inhibitors in the USA
Elizabeth Wehler et al.
PHARMACOECONOMICS (2020)
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
Myles Wolf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
P585 Evaluation and comparison of the safety profiles of different intravenous iron preparations and oral iron for treatment of iron deficiency anaemia: Preliminary results from the IBD subgroup analysis
A Aksan et al.
Journal of Crohns & Colitis (2020)
A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom
Richard F. Pollock et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside
Trond Espen Detlie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
Tristan Baguet et al.
FRONTIERS IN ONCOLOGY (2019)
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
Matiar Madanchi et al.
INFLAMMATORY BOWEL DISEASES (2018)
Oral iron exacerbates colitis and influences the intestinal microbiome
Awad Mahalhal et al.
PLOS ONE (2018)
Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
Krithika Rajagopalan et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis
Vibeke Strand et al.
BMC RHEUMATOLOGY (2018)
Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014
Caroline Bahler et al.
BMC GASTROENTEROLOGY (2017)
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply
A. Aksan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies
W. Reinisch et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
A. Aksan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naive patients with psoriasis
April W. Armstrong et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases
Axel U. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2015)
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease A Systematic Review
Ole Haagen Nielsen et al.
MEDICINE (2015)
Iron-Deficiency Anemia
Clara Camaschella
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)
Walter Reinisch et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis
R. Riemsma et al.
HEALTH TECHNOLOGY ASSESSMENT (2013)
Cost Per Responder Associated with Biologic Therapies for Crohn's Disease, Psoriasis, and Rheumatoid Arthritis
Yifei Liu et al.
ADVANCES IN THERAPY (2012)
A comparison of cost per case detected of screening strategies for Type 2 diabetes and impaired glucose regulation: Modelling study
Kamlesh Khunti et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Costs of infertility treatment: results from an 18-month prospective cohort study
Patricia Katz et al.
FERTILITY AND STERILITY (2011)
FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease
Rayko Evstatiev et al.
GASTROENTEROLOGY (2011)
Cost-utility analysis: current methodological issues and future perspectives
Mark J. C. Nuijten et al.
FRONTIERS IN PHARMACOLOGY (2011)
Prevalence of anaemia in inflammatory bowel disease in Switzerland: A cross-sectional study in patients from private practices and university hospitals
Manuela Voegtlin et al.
JOURNAL OF CROHNS & COLITIS (2010)
Rapid Recurrence of IBD-Associated Anemia and Iron Deficiency After Intravenous Iron Sucrose and Erythropoietin Treatment
Stefanie Kulnigg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study
Stefan Lindgren et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Anemia and inflammatory bowel diseases
Fernando Gomollon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease:: The ferric carboxymaltose (FERINJECT®) randomized controlled trial
Stefanie Kulnigg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study
Pascal Juillerat et al.
JOURNAL OF CROHNS & COLITIS (2008)
Systematic review: managing anaemia in Crohn's disease
S. Kulnigg et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients
CW Wells et al.
INFLAMMATORY BOWEL DISEASES (2006)
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease -: A randomized, controlled, open-label, multicenter study
O Schröder et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease
K Erichsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis
J Carrier et al.
JOURNAL OF NUTRITION (2002)
Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis
J Carrier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
